Results 21 - 40 of 1,015 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Show only
Refined by:
resource type:
Web Resources
| Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
|---|---|---|---|
| 21 |
Material Type: Web Resources
|
|
Benzinga: Bristol Myers Unveils More Mavacamten Data To Backup Case For Heart DrugNewstex Finance & Accounting Blogs, 2021Copyright Newstex May 17, 2021Digital Resources/Online E-Resources |
| 22 |
Material Type: Web Resources
|
|
Benzinga: Cytokinetics' Heart Drug Is A Multi-Billion Dollar Opportunity By 2032 Despite Novartis Setback: AnalystNewstex Finance & Accounting Blogs, 2024Copyright Newstex Jan 12, 2024Digital Resources/Online E-Resources |
| 23 |
Material Type: Web Resources
|
|
NJ Spotlight - WNET Spotlight LLC: Pallones fight against sudden cardiac arrest in kidsNJ Spotlight News, 2023Copyright Newstex Dec 19, 2023Digital Resources/Online E-Resources |
| 24 |
Material Type: Web Resources
|
|
24/7 Wall St.: Could Applied Therapeutics Stock Rise 300%?Newstex Finance & Accounting Blogs, 2020Copyright Newstex Oct 8, 2020Digital Resources/Online E-Resources |
| 25 |
Material Type: Web Resources
|
|
PharmaTimes: First treatment for ‘broken heart syndrome’ trialledPharmaTimes, 2022Copyright Newstex Jun 29, 2022Digital Resources/Online E-Resources |
| 26 |
Material Type: Web Resources
|
|
Benzinga: Alnylam Reinforces Patisiran Data In Stiff Heart Disorder Before Heading For FDA ApprovalNewstex Finance & Accounting Blogs, 2022Copyright Newstex Oct 3, 2022Digital Resources/Online E-Resources |
| 27 |
Material Type: Web Resources
|
|
Benzinga: Sangamo's Fabry Disease Gene Therapy Continues To Show Encouraging Safety ProfileNewstex Finance & Accounting Blogs, 2022Copyright Newstex Aug 30, 2022Digital Resources/Online E-Resources |
| 28 |
Material Type: Web Resources
|
|
Trefis: Is Alnylam Stock Poised For More Gains After A Stellar 50% Rise In A Month?Newstex Finance & Accounting Blogs, 2022Copyright Newstex Aug 22, 2022Digital Resources/Online E-Resources |
| 29 |
Material Type: Web Resources
|
|
PharmaTimes: NICE rejects Pfizer’s rare heart disease treatment VyndaqelPharmaTimes, 2021Copyright Newstex May 12, 2021Digital Resources/Online E-Resources |
| 30 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 30, 2023Digital Resources/Online E-Resources |
| 31 |
Material Type: Web Resources
|
|
GuruFocus.com: Cytokinetics Inc (CYTK) Q1 2024 Earnings Call Transcript Highlights: Navigating ThroughNewstex Finance & Accounting Blogs, 2024Copyright Newstex May 9, 2024Digital Resources/Online E-Resources |
| 32 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 17, 2023Digital Resources/Online E-Resources |
| 33 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 9, 2023Digital Resources/Online E-Resources |
| 34 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Nov 1, 2023Digital Resources/Online E-Resources |
| 35 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Oct 23, 2023Digital Resources/Online E-Resources |
| 36 |
Material Type: Web Resources
|
|
American Banking and Market News - American Consumer News: Hemostemix Inc. (HEM.V) (CVE:HEM) Stock Price Passes Below Fifty Day Moving Average of $0.49Newstex Finance & Accounting Blogs, 2021Copyright Newstex Feb 27, 2021Digital Resources/Online E-Resources |
| 37 |
Material Type: Web Resources
|
|
Watchlist News - American Consumer News: Hemostemix Inc. (HEM.V) (CVE:HEM) Stock Price Passes Below Fifty Day Moving Average of $0.49Newstex Finance & Accounting Blogs, 2021Copyright Newstex Feb 27, 2021Digital Resources/Online E-Resources |
| 38 |
Material Type: Web Resources
|
|
Newsfile Corp.: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Alnylam Pharmaceuticals, Inc. - ALNYNewstex Finance & Accounting Blogs, 2023Copyright Newstex Oct 15, 2023Digital Resources/Online E-Resources |
| 39 |
Material Type: Web Resources
|
|
American Banking and Market News - American Consumer News: Hemostemix Inc. (HEM.V) (CVE:HEM) Stock Price Passes Below 50 Day Moving Average of $0.46Newstex Finance & Accounting Blogs, 2021Copyright Newstex Feb 11, 2021Digital Resources/Online E-Resources |
| 40 |
Material Type: Web Resources
|
|
American Banking and Market News - American Consumer News: Hemostemix Inc. (HEM.V) (CVE:HEM) Shares Gap Down to $0.59Newstex Finance & Accounting Blogs, 2021Copyright Newstex Feb 1, 2021Digital Resources/Online E-Resources |
Results 21 - 40 of 1,015 for All Library Resources
Sorted by:
Sorted by:
RelevanceOr hit Enter to replace sort method
- Relevance
- Date-newest
- Date-oldest
- Popularity
- Author
- Title
Personalize your results
Refine Search Results
Expand My Results
Show only
Refine My Results
Creation Date
- Before 1997 (3)
- 1997 To 2010 (15)
- 2011 To 2014 (15)
- 2015 To 2018 (280)
- After 2018 (626)
-
More options
New Records
Subject
- Cardiomyopathy (906)
- Earnings Per Share (443)
- Institutional Investments (333)
- Gene Therapy (289)
- Clinical Trials (213)
- Stock Prices (169)
- Hedge Funds (129)
- Ratings & Rankings (129)
- Investments (123)
- Heart Failure (119)
- Ischemia (118)
- Stem Cells (111)
- Corporate Profits (109)
- Valuation (98)
- Medizin, Gesundheit (81)
- Covid-19 (79)
- Biotechnology Industry (78)
- Pandemics (74)
- Stocks (69)
- Coronaviruses (68)
-
More options
Databases
- ProQuest Central (874)
- Europeana Collections (94)
- Freely Accessible Journals (9)
- Leiden University Repository (8)
- DOAJ Directory of Open Access Journals (7)
- ProQuest One Psychology (5)
- PubMed Central (4)
- ROAD: Directory of Open Access Scholarly Resources (4)
- Cambridge University Library IR - DSpace@Cambridge (3)
- Springer Open Access Journals (1)
- HighWire Press (Free Journals) (1)
- Utrecht University Repository (1)
- Diposit Digital de la Universitat de Barcelona (1)
- Iowa State Digital Repository (1)
- Harvard University Library DASH (1)
- Open Access: Oxford University Press Open Journals (1)
- UAB Digital Repository (1)
-
More options
|
||||
 |
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY |  |
(84-028) 37 755 057 | Feedback |
| 19 Nguyen Huu Tho St. Dist.7, HCM |  |
thuvien@tdtu.edu.vn | ||